comparemela.com
Home
Live Updates
Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patient : comparemela.com
Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patient
LUND, Sweden, July 17, 2023 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced topline, interim data...
Related Keywords
Sweden ,
Stockholm ,
Italy ,
Swedish ,
Fredrik Tiberg ,
Diego Ferone ,
University Of Genova ,
Business Development Officertel ,
Camuru President ,
Acromegaly Index ,
Patient Satisfaction ,
Treatment Satisfaction Questionnaire ,
Acromegaly Quality ,
Life Questionnaire ,
Internal Medicine ,
Medical Specialties ,
Policlinico San Martino ,
Nasdaq Stockholm ,
Chief Business Development ,
comparemela.com © 2020. All Rights Reserved.